Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Cysic Cysic +23.33%
#4 Solv Protocol xSolvBTC Solv Protocol xSolvBTC +22.84%
#5 Victoria VR Victoria VR +21.15%
#6 Nockchain Nockchain +18.95%
#7 Bedrock Bedrock +17.00%
#8 Versatize Coin Versatize Coin +12.50%
#9 Perle Perle +12.25%
#10 Velvet Velvet +12.00%
Coin of the day
EXOD EXOD
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Rangering i aksjer #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Aksjekurs
$0.00060315
Sist synkronisert: 2024-09-27
Markedsverdi
$1.65M
Endring (1 dag)
19.64%
Endring (1 år)
0.00%
Land
SE
Handel Amniotics AB (publ) (AMNI)

Kategori

Healthcare
Inntekter for Amniotics AB (publ) (AMNI)
Inntekter i Dec 2023 TTM: $-3.09M
Ifølge Amniotics AB (publ) sine nyeste økonomiske rapporter er selskapets nåværende resultat $-3.09M. I 2022 hadde selskapet et resultat på $-4.61M, en økning sammenlignet med resultatet i 2021, som var $-5.92M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Amniotics AB (publ) fra 2018 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $-3.09M 0.85%
2023 $-3.06M -33.59%
2022 $-4.61M -22.23%
2021 $-5.92M 57.96%
2020 $-3.75M 235.76%
2019 $-1.12M 45.50%
2018 $-767.77K 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -171,033.57%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -63,310.98%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -97,500.51%
BE